Skip to content

百奥技术

US · TECH #1365 按市值排名 上市于 1970
72.57 +0.05 +0.07%
实时 - 追踪5344个代码 - 心跳于539秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了4家。
  • 机构持股总比例下降了0.5个百分点。

机构持股

机构持股比例
113.54% -0.49pp
机构数量
686 -4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund86.05%
Hedge Fund15.62%
Public Company7.43%
Government Pension Fund1.57%
Private Company0.92%
Sovereign Wealth Fund0.90%
Family Office/Trust0.45%
Insurance Company0.39%
Individual/Insider0.35%

主要股东 截至 2026-06-30

BlackRock 8.94% · 14.03M 股
FMR 8.14% · 12.76M 股
Vanguard Capital Management, LLC 7.08% · 11.10M 股
HBK Investments L.P. 4.35% · 6.83M 股
Vanguard Portfolio Management, LLC 4.15% · 6.51M 股
The Goldman Sachs Group, Inc. 4.00% · 6.27M 股
State Street Global Advisors 3.81% · 5.98M 股
Geode Capital Management, LLC 3.41% · 5.35M 股
Eaton Vance Management 3.05% · 4.78M 股
Invesco Capital Management LLC 2.89% · 4.54M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 26次卖出

姓名职务持股比例
James Hippel Chief Financial Officer 0.11%
Kim Kelderman President of Diagnostics & Genomics 0.05%
John Higgins Independent Director 0.05%
Robert Baumgartner Independent Chairperson 0.04%
Roeland Nusse Independent Director 0.03%
William Geist President of Protein Sciences Segment 0.02%
Alpna Seth Independent Director 0.01%
Joseph Keegan Independent Director 0.01%
S.J. Vessey Independent Director 0.01%
Shane Bohnen Senior Vice President 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-27 John Higgins Independent Director Derivative Exercise and Sale -5,562 $72.51
2026-09-27 John Higgins Independent Director Derivative Exercise and Retained +10,378 --
2026-09-21 Robert Baumgartner Independent Chairperson Derivative Exercise and Sale -5,559 $72.55
2026-09-21 Robert Baumgartner Independent Chairperson Derivative Exercise and Retained +10,381 --
2026-08-16 Kim Kelderman President of Diagnostics & Genomics Other Derivative Acquisition +151,172 --
2026-08-16 Steven Crouse Senior Vice President of Analytical Solutions Division Other Derivative Acquisition +22,842 --
2026-08-16 James Hippel Chief Financial Officer Other Derivative Acquisition +58,897 --
2026-08-16 Amy Herr Independent Director Other Derivative Acquisition +1,381 --
2026-08-16 William Geist President of Protein Sciences Segment Other Derivative Acquisition +38,747 --
2026-08-16 Shane Bohnen Senior Vice President Other Derivative Acquisition +29,776 --
2026-08-14 Kim Kelderman President of Diagnostics & Genomics Derivative Sale to Issuer -46,713 --
2026-08-14 Kim Kelderman President of Diagnostics & Genomics Derivative Sale to Issuer -17,154 --
2026-08-14 Kim Kelderman President of Diagnostics & Genomics Derivative Exercise and Sale -10,821 $72.40
2026-08-14 Kim Kelderman President of Diagnostics & Genomics Derivative Exercise and Retained +10,649 --
2026-08-14 Steven Crouse Senior Vice President of Analytical Solutions Division Derivative Exercise and Sale -1,947 $72.40
2026-08-14 Steven Crouse Senior Vice President of Analytical Solutions Division Derivative Exercise and Retained +3,476 --
2026-08-14 James Hippel Chief Financial Officer Derivative Sale to Issuer -34,982 --
2026-08-14 James Hippel Chief Financial Officer Derivative Sale to Issuer -12,999 --
2026-08-14 James Hippel Chief Financial Officer Derivative Exercise and Sale -4,310 $72.40
2026-08-14 James Hippel Chief Financial Officer Derivative Exercise and Retained +5,469 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

百奥技术 讨论区 0 条评论

发表评论